Twist Bioscience
TWST
Twist Bioscience (TWST) - P/B ratio
P/B ratio as of May 2024 : 4.83
According to Twist Bioscience
's latest financial reports the company has a price-to-book ratio of 4.83.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Twist Bioscience - P/B ratio (from 2018 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 3.60 | 99.64% |
| 2022-12-31 | 1.80 | -71.22% |
| 2021-12-31 | 6.27 | -41.31% |
| 2020-12-31 | 10.7 | 57.68% |
| 2019-12-31 | 6.78 | 45.19% |
| 2018-12-31 | 4.67 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.92 | -60.22% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | -2.02% | 🇬🇧 UK |
 Novavax NVAX | -2.96 | -161.21% | 🇺🇸 USA |
 Novocure
NVCR | 6.64 | 37.35% | Jersey |